当前位置: X-MOL 学术Neurol. Sci. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports.
Neurological Sciences ( IF 3.3 ) Pub Date : 2020-09-02 , DOI: 10.1007/s10072-020-04693-y
Kaveh Rahimi 1
Affiliation  

Similar to severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), the coronavirus disease 2019 (COVID-19) has neurological symptoms. COVID-19 patients have such clinical symptoms as headache, vomiting, nausea, dizziness, myalgia, anosmia, ageusia, and disorder of consciousness. These symptoms confirm that the nervous system is involved in the COVID-19 infection. Guillain-Barré syndrome (GBS) is a heterogeneous disorder which often follows a viral infection. According to the assessment case reports from the beginning of the COVID-19 infection so far, it is possible that GBS is linked to the COVID-19 infection. It seems that paying attention to the neurological effects of COVID-19 is necessary.



中文翻译:

COVID-19 大流行期间的格林-巴利综合征:报告概述。

与严重急性呼吸综合征冠状病毒 (SARS-CoV) 和中东呼吸综合征冠状病毒 (MERS-CoV) 相似,2019 年冠状病毒病 (COVID-19) 具有神经系统症状。COVID-19患者有头痛、呕吐、恶心、头晕、肌痛、嗅觉丧失、听力丧失和意识障碍等临床症状。这些症状证实了神经系统与 COVID-19 感染有关。格林-巴利综合征 (GBS) 是一种异质性疾病,通常在病毒感染后发生。根据从 COVID-19 感染开始至今的评估案例报告,GBS 可能与 COVID-19 感染有关。似乎有必要关注 COVID-19 的神经系统影响。

更新日期:2020-09-02
down
wechat
bug